Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-Stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c02136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Saurabh Upadhyay und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, New York 10065, United States. Hauptthemen laut MEDLINE: CD28 Antigens, T-Lymphocytes, Small Molecule Libraries, Drug Discovery. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
CD28 is a key T cell costimulatory receptor implicated in antitumor immunity and immune-related disorders, yet no small molecule modulators of CD28 have reached clinical development. Here, we report the discovery and characterization of small molecule CD28 antagonists identified through affinity selection-mass spectrometry (AS-MS). Subsequent catalog-based structure–activity relationship (SAR) optimization led to the identification of validated hits, 5MS-5 and 19MS-5, which exhibit direct CD28 binding and potent inhibition of CD28-B7 interactions in cellular reporter assays. Pharmacokinetic profiling demonstrated favorable solubility, metabolic stability, permeability, and oral exposure in vivo. Functionally, both compounds suppressed cytokine production in primary human T cells cocultured with tumor spheroids and human epithelial tissues, validating their ability to inhibit CD28-driven immune activation in physiologically relevant models. These findings establish 5MS-5 and 19MS-5 as promising CD28 inhibitors and provide a foundation for developing orally bioavailable immunomodulators targeting T cell costimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, New York 10065, United States.
ORCID-Profile: Saurabh Upadhyay, Moustafa T Gabr
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Upadhyay, S., Cho, S., Nada, H., & Gabr, M. T. (2025). Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-Stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02136
Vancouver
Upadhyay S, Cho S, Nada H, Gabr MT. Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-Stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02136
BibTeX
@article{Upadhyay2025,
author = {Upadhyay, Saurabh and Cho, Sungwoo and Nada, Hossam and Gabr, Moustafa T},
title = {Discovery of CD28-Targeted Small Molecule Inhibitors of T Cell Co-Stimulation Using Affinity Selection-Mass Spectrometry (AS-MS) and Ex Vivo Validation},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c02136}
}
EUVIMED